At A Glance- AMO-pharma.com

Home
About
Pipeline
- AMO-01
- AMO-02
- AMO-04
Patients
Partnerships
News
Contact Us

About
AMO Pharma at a Glance

AMO PHARMA FACT SHEET

AMO PHARMA FACT SHEET

Contact Us

London UK Office
AMO Pharma, Ltd.,
1 Park Row,
Leeds LS1 5AB UK
Phone: Tel: +44 (0) 1483 319070
Email: info@amo-pharma.com

North Carolina US Office
321 East Chapel Hill Street
3rd Floor
Durham, NC 27701
Phone: 919-383-1400
Fax: 919-383-1433
Email: info@amo-pharma.com

Patient Drug Trial Information
Email: info@reachcdm.com

Site Map

HOME

AMO Pharma at a Glance

Phelan-McDermid Syndrome

Congenital Myotonic Dystrophy

PARTNERSHIPS

NEWS

Latest News

Press Release - May 2, 2024

AMO Pharma Completes Meeting with U.S. FDA and Outlines Plans to Advance Clinical Development of AMO-02 (tideglusib) in Treatment of Myotonic Dystrophy More News

© AMO Pharma All rights reserved. | Privacy Policy | Cookie Policy